18 Dec (NucNet): The production of the most widely used medical radioisotope, molybdenum-99 (Mo-99), depends largely on a small number of reactors that are ageing and facing unplanned outages, refurbishment outages or permanent shutdowns, increasing the risk of disruption to the supply chain, a joint declaration signed by 11 countries says.
…
Joint Declaration Calls For Global Action On Mo-99 Security Of Supply
Source: NucNet
Archived news summary. This item reflects its original publication date. Follow the source link below for the publisher’s full article.
Questions about this archived item? Contact Nuclear Street.